Karyopharm Therapeutics I...

NASDAQ: KPTI · Real-Time Price · USD
5.96
1.31 (28.17%)
At close: Aug 15, 2025, 3:59 PM
5.60
-6.01%
After-hours: Aug 15, 2025, 07:58 PM EDT

Karyopharm Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-76.42M -143.1M -165.29M -124.09M
Depreciation & Amortization
340K 530K 621K 789K
Stock-Based Compensation
18.43M 21.71M 35.4M 29.78M
Other Working Capital
3.21M 9.76M -15.96M -9.26M
Other Non-Cash Items
-69.53M -3.28M -294K 8.13M
Deferred Income Tax
n/a n/a n/a 1.45M
Change in Working Capital
-302K 31.41M -19.99M -23.19M
Operating Cash Flow
-127.49M -92.72M -149.55M -107.12M
Capital Expenditures
-142K n/a -118K -5.71M
Cash Acquisitions
n/a n/a 104.26M 5.5M
Purchase of Investments
-58.82M -159.15M -226.02M -45.23M
Sales Maturities Of Investments
154.44M 167.09M 121.88M 192.78M
Other Investing Acitivies
n/a n/a -104.26M -5.5M
Investing Cash Flow
95.47M 7.94M -104.26M 141.84M
Debt Repayment
83.3M n/a n/a 60M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-43.11M n/a 3.98M 3.75M
Financial Cash Flow
41.65M 1.12M 193.74M 73.65M
Net Cash Flow
9.62M -83.69M -60.56M 108.32M
Free Cash Flow
-127.63M -92.72M -149.67M -112.83M